Brief: Windtree Reports Q1 2022 Results And Provides Key Business Updates
May 5 (Reuters) - Windtree Therapeutics Inc WINT.O :
* WINDTREE THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES KEY BUSINESS UPDATES
* WINDTREE THERAPEUTICS INC - AS OF MAY 5, 2022, COMPANY
BELIEVES
THAT IT HAS SUFFICIENT CASH RESOURCES TO PROVIDE RUNWAY INTO Q1
OF 2023
* WINDTREE THERAPEUTICS INC - QTRLY NET LOSS PER COMMON
SHARE
$0.29
Source text for Eikon: ID:nGNXb0hYmv
Further company coverage: WINT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study